Global Commercial Lead, Rare Neurology

Alexion, AstraZeneca Rare Disease

Boston, MA, US
Base: $231,988.80 - $347,983.20 usd annually; bonu...
Hybrid
10 years pharmaceutical commercial experience
Neurology rare disease expertise
Pre-launch and launch experience
The role drives the commercial development and successful global launch of ALXN-2230 for rare neurology indications including IIM, wAIHA, and gMG

Job Summary

  • The role drives the commercial development and successful global launch of ALXN-2230 for rare neurology indications including IIM, wAIHA, and gMG.
  • Candidates must possess a deep understanding of technical risks and their implications for future brand commercialization within complex markets.
  • The position offers a competitive annual base pay ranging from $231,988.80 to $347,983.20 USD along with short-term incentives and equity-based long-term programs.

Matching Summary

The role drives the commercial development and successful global launch of ALXN-2230 for rare neurology indications including IIM, wAIHA, and gMG.

Salary

Base: $231,988.80 - $347,983.20 USD annually; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: 401(k), paid vacation, health/dental/vision coverage

Skills & Requirements

Must-have

  • 10 years pharmaceutical commercial experience
  • Neurology rare disease expertise
  • Pre-launch and launch experience
  • Clinical data driven strategy
  • Revenue forecasting and budget management

Nice-to-have

  • Advanced degree MBA MSc or PhD
  • Hematology disease area knowledge
  • Strategic project leadership
  • Innovative go-to-market tactics
  • Cross-functional matrix collaboration

Key Requirements

  • Bachelor's degree in Business Medical or Life sciences
  • 10 years pharmaceutical commercial experience
  • Proven pre-launch and launch experience
  • Experience with revenue forecasting and business case development

Work Rights

Not specified

Tailored Resume

Cover Letter